You just read:

Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) on Behalf of Progenics Shareholders and Encourages Progenics Investors to Contact the Firm

News provided by

Bragar Eagel & Squire, P.C.

Oct 02, 2019, 17:04 ET